(PDF) P3.12-06 SLFN11 Expression and Efficacy of PARP

P3.12-06 SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1829

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

MA22.01 PARP Inhibitor Radiosensitization of Small Cell Lung Cancer Differs by PARP Trapping Potency

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.12-14 Genomic Profiling of Chinese Small Cell Lung Cancer and the Implications for Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

Immunotherapy in Extensive Small Cell Lung Cancer

Experimental Hematology and Oncology

Cancer Research

English

P3.12-13 Expression of the Immune Checkpoint Axis-PVR/Tigit in Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Prospective Study of Proton-Beam Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Cancer Research

English

Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

P3.12-16 Prognostic Impact of M Descriptors of the 8th Edition of TNM Classification for Extensive Disease-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English